Press Release Distribution and Management

November 25, 2024 07:30 ET | Source: Plus Therapeutics Inc.

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference

Want to stay updated on the latest news?